Home › Kidney Cancer (Renal Cell Carcinoma) › Louisiana › Metairie
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Metairie, LA
4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Metairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- East Jefferson General Hospital, Metairie
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Mary Bird Perkins Cancer Center - Metairie, Metairie
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- Mary Bird Perkins Cancer Center - Metairie, Metairie
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- East Jefferson General Hospital, Metairie
- LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Philadelphia, PA15 studies
- Pittsburgh, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Other studies in Metairie
- Prostate Cancer12 studies
- Ulcerative Colitis8 studies
- Bladder Cancer6 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Crohn's Disease5 studies
- Steatotic Liver Disease4 studies
- Metastatic Cancer4 studies
- Cardiovascular Disease4 studies
- Neuroendocrine Tumors3 studies
- Urothelial (Transitional Cell) Carcinoma3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.